Expression of BMP-7 in human gastric cancer and its clinical significance.

Expression of BMP-7 in human gastric cancer and its clinical significance.
复制标题

DOI:
10.1038/sj.bjc.6606075
复制
发表时间:
2011-02-15
影响因子:
8.8
通讯作者:
--
中科院分区:
医学1区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

骨形态发生蛋白-7(BMP-7)是属于转化生长因子超家族的信号分子。最近的研究已经证明了BMP-7表达在各种人类癌症中的临床影响。然而,很少有报道详细介绍这在胃癌。为探讨BMP-7阳性胃癌的临床病理特征,我们采用免疫组化方法检测了233例胃癌组织中BMP-7的表达。免疫组化显示,在人胃癌中,BMP-7表达不仅在细胞膜中,而且在癌细胞的细胞质中。骨形态发生蛋白7阳性表达129例(55%)。骨形态发生蛋白-7表达与肿瘤大小、淋巴结转移、静脉浸润及组织学类型有关(P<0.05)。骨形态发生蛋白-7的表达与患者的术后结果显著相关,尤其是在未分化组。多因素分析显示,BMP-7表达是仅次于浸润深度和淋巴结转移的独立预后因素(P<0.01)。从收集的数据,这将是适当的结论胃癌进展的可能调控自分泌或旁分泌BMP-7环。我们可以使用BMP-7表达作为胃癌肿瘤复发风险的强有力的预测因子之一。
Bone morphogenetic protein-7 (BMP-7) is a signalling molecule belonging to the transforming growth factor--superfamily. Recent studies have demonstrated the clinical impact of BMP-7 expression in various human cancers. However, there have been few reports detailing this in gastric cancer. We immunohistochemically investigated the expression of BMP-7 in 233 gastric cancer patients to disclose the clinicopathological features of BMP-7-positive gastric cancer. Immunohistochemically, in human gastric cancer, BMP-7 expression was identified in cellular membranes but also in the cytoplasm of cancer cells. Bone morphogenetic protein-7-positive expression was found in 129 of 233 patients (55%). Bone morphogenetic protein-7 expression was correlated with tumour size, nodal involvement, lymphatic invasion, venous invasion and histology (P<0.05). Bone morphogenetic protein-7 expression was significantly correlated with patient postoperative outcome, especially in the undifferentiated group. Multivariate analysis revealed BMP-7 expression as one of the independent prognostic factors next to the depth of invasion and nodal involvement (P<0.01). From the data collected, it would be appropriate to conclude on the possible regulation of gastric cancer progression by autocrine or paracrine BMP-7 loops. We can use BMP-7 expression as one of the strong predictors of risk of tumour recurrence in gastric cancer.
DOI: 10.1093/annonc/mdm453
发表时间: 2008-02-01
期刊: ANNALS OF ONCOLOGY
影响因子: 50.5
作者:
Alarmo, E. -L.;Korhonen, T.;Kallioniemi, A.
通讯作者: Kallioniemi, A.
DOI: 10.1016/j.cellsig.2007.03.008
发表时间: 2007-08-01
影响因子: 4.8
作者:
Grijelmo, Clara;Rodrigue, Christelle;Gespach, Christian
通讯作者: Gespach, Christian
DOI: 10.1016/j.canlet.2008.09.028
发表时间: 2009-03-08
期刊: CANCER LETTERS
影响因子: 9.7
作者:
Alarmo, Emma-Leena;Parssinen, Jenita;Kallioniemi, Anne
通讯作者: Kallioniemi, Anne
DOI: 10.1038/nm888
发表时间: 2003-07-01
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
Zeisberg, M;Hanai, J;Kalluri, R
通讯作者: Kalluri, R
DOI: 10.2353/ajpath.2010.090459
发表时间: 2010-03-01
影响因子: 6
作者:
Luo, Dong Dong;Phillips, Aled;Fraser, Donald
通讯作者: Fraser, Donald